Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
Context: Multiple drug resistance is the major obstacle to conventional chemotherapy.
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy.
O Molavi, F Narimani, F Asiaee, S Sharifi… - Pharmaceutical …, 2017 - europepmc.org
Objective To evaluate the effects of silibinin on enhancing the sensitivity of chemo-resistant
human breast cell lines to doxorubicin (DOX) and paclitaxel (PAC). Materials and methods …
human breast cell lines to doxorubicin (DOX) and paclitaxel (PAC). Materials and methods …
Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
O Molavi, F Narimani, F Asiaee, S Sharifi… - Pharmaceutical …, 2017 - search.proquest.com
Context: Multiple drug resistance is the major obstacle to conventional chemotherapy.
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy.
O Molavi, F Narimani, F Asiaee, S Sharifi, V Tarhriz… - 2017 - cabidigitallibrary.org
Context: Multiple drug resistance is the major obstacle to conventional chemotherapy.
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
[PDF][PDF] Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
O Molavi, F Narimani, F Asiaee, S Sharifi… - PHARMACEUTICAL … - scholar.archive.org
Context: Multiple drug resistance is the major obstacle to conventional chemotherapy.
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
[HTML][HTML] Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
O Molavi, F Narimani, F Asiaee, S Sharifi… - Pharmaceutical …, 2017 - ncbi.nlm.nih.gov
Context: Multiple drug resistance is the major obstacle to conventional chemotherapy.
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy.
O Molavi, F Narimani, F Asiaee, S Sharifi… - Pharmaceutical …, 2017 - search.ebscohost.com
Context: Multiple drug resistance is the major obstacle to conventional chemotherapy.
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
O Molavi, F Narimani, F Asiaee… - Pharmaceutical …, 2017 - pubmed.ncbi.nlm.nih.gov
Context Multiple drug resistance is the major obstacle to conventional chemotherapy.
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
[PDF][PDF] Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy
O Molavi, F Narimani, F Asiaee, S Sharifi… - PHARMACEUTICAL … - scienceopen.com
Context: Multiple drug resistance is the major obstacle to conventional chemotherapy.
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …
Silibinin, a nontoxic naturally occurring compound, has anticancer activity and can increase …